Aptamer blocking S-TLR4 interaction selectively inhibits SARS-CoV-2 induced inflammation

Gang Yang(Sichuan University), Yongyun Zhao(Sichuan University), Fatao Luo(Sichuan University), Yu Li(Guangdong Pharmaceutical University), Ling Li(Zhejiang Shuren University), Shengnan Zhang(Peking University), Yuchun Wang(Sichuan University), Deyu Yuan(Sichuan University), Xu Song(Sichuan University), Jincun Zhao(ShanghaiTech University)
Signal Transduction and Targeted Therapy
April 11, 2022
10.1038/s41392-022-00968-2
Cited by 36

Related Papers

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
|Cell Reports|2020|450
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
|bioRxiv (Cold Spring Harbor Laboratory)|2020|101
Iron doped carbon dots based nanohybrids as a tetramodal imaging agent for gene delivery promotion and photothermal-chemodynamic cancer synergistic theranostics
|Materials & Design|2021|74
Multiple antiviral approaches of (–)-epigallocatechin-3-gallate (EGCG) against porcine reproductive and respiratory syndrome virus infection in vitro
|Antiviral Research|2018|67